Letter to Editor
Treatment of atrophic cutaneous leishmaniasis scar using autologous fibroblasts and keratinocytes (a case report and literature review) JRMS 2010; 15(2): 125-126 utaneous leishmaniasis is an endemic disease of Iran. Unfortunately, there is no definite treatment for this disease. 1 We report a 21-year-old woman who was infected with cutaneous leishmaniasis about 16 years ago with disfiguring scar (Figure 1 ). Different methods of resurfacing were taken without significant results. To repair the scar, at first, a biopsy was performed from retroauricular area and was sent for Rooyan where culture of fibroblasts was performed. A mixture of 20 millions fibroblasts in 1 cc of serum was injected beneath the scar area with about 100% correction. After 2 months, fibroblast suspension was injected again. The scar area was then dermabraded until blood oozing was occurred. The dermabraded area was covered with a thin layer of Fibrin Glue, fibroblast and keratinocyte suspension. The dressing was removed 2 weeks later. The appearance of scar was significantly improved at 3-month followup. According to two blinded investigators and the patient herself, there was at least 80% and 90% improvement, respectively, in the cosmetic appearance of the scar (Figure 1) .
Leishmaniasis scars are usually depressed and atrophic. Patients affected by these scars usually have psychosocial and cosmetic complains. 2 The result at 3 months follow up was very interesting and the cosmetic appearance of leishmaniasis scar was at least 90% improved according to the patient and investigators. More prolonged studies on further cases are recommended for better evaluation of this method in the treatment of atrophic scars. 
